Preventive physical activity for head and neck cancer patients
Preventive Randomized Study Regarding Physical Activity Intervention for Patients Receiving Radiotherapy for Head and Neck Cancer: the Effect of Preventive Intervention for Physical Activity, Function and Quality of Life
This study tests if a special exercise program can help head and neck cancer patients feel better and function well during their radiation treatment.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 80 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Sahlgrenska University Hospital Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Gothenburg) |
| Trial ID | NCT05432297 on ClinicalTrials.gov |
What this trial studies
This study involves patients with tumors of the oropharynx, larynx, and hypopharynx who are scheduled to receive radiotherapy with curative intent. Participants will be randomly assigned to either a preventive physical activity intervention group or a control group that does not engage in a specified exercise protocol. Throughout the treatment, all patients will receive weekly support from a speech language pathologist or physical therapist. The aim is to enhance physical function and improve quality of life during and after oncologic treatment.
Who should consider this trial
Good fit: Ideal candidates are patients diagnosed with head and neck cancer who are set to receive radiotherapy with curative intent.
Not a fit: Patients who have undergone surgery for head and neck cancer or those unable to participate in the exercise intervention will not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve physical function and quality of life for patients undergoing treatment for head and neck cancer.
How similar studies have performed: While similar approaches have been explored, this specific preventive physical activity intervention in the context of head and neck cancer treatment is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Head and neck cancer (tumors of the oropharynx, pharynx, hypopharynx and larynx) * Receiving radiohterapy (+/- chemotherapy) with curative intent Exclusion Criteria: * Surgery due to head and neck cancer * Previous treatment for head and neck cancer * Tracheostomized patients * Inability to perform exercise intervention * Inability to perform part of 6-minute walking test * Inability to independently fill out questionnaires in Swedish * Previous neurologic or neuromuscular disease
Where this trial is running
Gothenburg
- Sahlgrenska University Hospital — Gothenburg, Sweden (Recruiting)
Study contacts
- Principal investigator: Lisa Tuomi, PhD — Sahlgrenska University Hospital
- Study coordinator: Lisa Tuomi, PhD
- Email: tuomi.lisa@gu.se
- Phone: +46313421000
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.